Results 61 to 70 of about 968,734 (398)
Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing
Therapeutic Advances in Vaccines and Immunotherapy, 2020 Influenza continues to cause severe illness in millions and deaths in hundreds of thousands annually. Vaccines are used to prevent influenza outbreaks, however, the influenza virus mutates and annual vaccination is required for optimal protection ...
S. Rajaram +3 more
semanticscholar +1 more source
Virus-Vectored Influenza Virus Vaccines
Viruses, 2014 Despite the availability of an inactivated vaccine that has been licensed for >50 years, the influenza virus continues to cause morbidity and mortality worldwide.
Ralph A. Tripp, S. Mark Tompkins
doaj +1 more source
New Technologies for Influenza Vaccines
Microorganisms, 2020 Vaccine development has been hampered by the long lead times and the high cost required to reach the market. The 2020 pandemic, caused by a new coronavirus (SARS-CoV-2) that was first reported in late 2019, has seen unprecedented rapid activity to ...
S. Rockman +4 more
semanticscholar +1 more source
Impact of communicative and informative strategies on influenza vaccination adherence and absenteeism from work of health care professionals working at the university hospital of palermo, Italy: A quasi-experimental field trial on twelve influenza seasons [PDF]
, 2019 Every year, about 20% of health care workers (HCWs) acquire influenza, continuing to work and encouraging virus spreading. Influenza vaccination coverage rates and absenteeism from work among HCWs of the University Hospital (UH) of Palermo were analyzed ...
Bono S. +8 more
core +1 more source
Adjuvanted influenza vaccines [PDF]
Human Vaccines & Immunotherapeutics, 2012 The search for adjuvants has been stimulated by the need to ensure greater protection against influenza among subjects who show a reduced immune response to conventional influenza vaccines. Aluminum salts have long been used but are not considered satisfactory.
N. Principi +1 more
openaire +7 more sources
MMWR Recommendations and ReportsSummary This report updates the 2023–24 recommendations of the Advisory Committee on Immunization Practices (ACIP) concerning the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2022;72[No. RR-2]:1–24).
L. Grohskopf +4 more
semanticscholar +1 more source
Next-Generation Influenza Vaccines.
Cold Spring Harbor Perspectives in Medicine, 2020 Most currently used conventional influenza vaccines are based on 1940s technology. Advances in vaccine immunogen design and delivery emerging over the last decade promise new options for improving influenza vaccines.
M. Kanekiyo, B. Graham
semanticscholar +1 more source
Human Vaccines & Immunotherapeutics, 2021 The influenza vaccine is not included in China’s national immunization program. Here, we assessed influenza vaccine coverage among Shanghai residents and estimated the impacts of the coronavirus disease 2019 (COVID-19) epidemic and a hypothetical free ...
Yehong Zhou +3 more
doaj +1 more source
Recombinant Influenza Vaccines [PDF]
Acta Naturae, 2012 This review covers the problems encountered in the construction and production of new recombinant influenza vaccines. New approaches to the development of influenza vaccines are investigated; they include reverse genetics methods, production of virus-like particles, and DNA- and viral vector-based vaccines.
Sedova, E. +9 more
openaire +4 more sources
Progress in the Development of Universal Influenza Vaccines
Viruses, 2020 Influenza viruses pose a significant threat to human health. They are responsible for a large number of deaths annually and have a serious impact on the global economy. There are numerous influenza virus subtypes, antigenic variations occur continuously,
Wenqiang Sun +3 more
semanticscholar +1 more source